Management of cardiac dysrhythmias complicating acute myocardial infarction.
D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy; D001949:Bretylium Compounds / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D004562:Electrocardiography; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009388:Neostigmine / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010042:Ouabain / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D014636:Valsalva Maneuver
D001949:Bretylium Compounds; D009388:Neostigmine; D010042:Ouabain; D010672:Phenytoin; D011189:Potassium Chloride; D001285:Atropine; D008680:Metaraminol; D008012:Lidocaine; D004492:Edetic Acid; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol; D003975:Diazepam; D006854:Hydrocortisone; D009638:Norepinephrine